Shaolin Capital Management’s PepperLime Health Acquisition Corporation Class A Ordinary Share PEPL Stock Holding History

Shaolin Capital Management’s Portfolio PEPL Stock Details PEPL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-55,000	Closed	-$597K	–	440
2023 Q4	$597K	Sell	55,000 -20,000	-27%	-$217K	0.02%	169
2023 Q3	$810K	Buy	+75,000	New	+$799K	0.03%	205
2023 Q2	–	Sell	-150,000	Closed	-$1.55M	–	870
2023 Q1	$1.53M	Sell	150,000 -900,000	-86%	-$9.17M	0.05%	267
2022 Q4	$10.7M	Hold	1,050,000	–	–	0.32%	74
2022 Q3	$10.5M	Buy	1,050,000 +25,000	+2%	+$248K	0.29%	86
2022 Q2	$10.1M	Buy	1,025,000 +75,000	+8%	+$740K	0.24%	89
2022 Q1	$9.35M	Sell	950,000 -50,000	-5%	-$491K	0.23%	96
2021 Q4	$9.8M	Buy	+1,000,000	New	+$9.76M	0.25%	90

Shaolin Capital Management's PEPL Position: Q1 2024 in Review

Shaolin Capital Management sold out of PepperLime Health Acquisition Corporation Class A Ordinary Share (PEPL) in Q1 2024, closing a stake of 55,000 shares — an estimated $597K sold.

Shaolin Capital Management first reported a position in PEPL in Q4 2021 and held it in 8 quarters. The position peaked at $10.7M in Q4 2022. 0 funds tracked by Wall St. Rank hold PEPL as of Q1 2024.

Shaolin Capital Management reported no remaining PepperLime Health Acquisition Corporation Class A Ordinary Share position as of Q1 2024 after selling out during the quarter.
Shaolin Capital Management sold 55,000 PepperLime Health Acquisition Corporation Class A Ordinary Share shares in Q1 2024, an estimated $597K.
Shaolin Capital Management first reported a position in PepperLime Health Acquisition Corporation Class A Ordinary Share in Q4 2021 and held it in 8 quarters.
Shaolin Capital Management's PepperLime Health Acquisition Corporation Class A Ordinary Share position peaked at $10.7M in Q4 2022.
0 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Class A Ordinary Share as of Q1 2024.

Based on Shaolin Capital Management's 13F filing for Q1 2024, filed 15 May 2024.